24/7 Patient Assistance: 760-405-8205

Matthew Gubens, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Matthew Gubens is a board-certified medical oncologist based in San Francisco, California. He graduated from the Stanford University School of Medicine and did his residency in internal medicine at the UCSF. He also did a fellowship in medical oncology at the Stanford University. He is specialized in the treatment of cancer affecting the larynx, lungs, and mesothelioma. With about two decades of clinical experience, Dr. Gubens is affiliated with the UCSF Medical Center and has also contributed to several research publications.

  • Education & Training


    Stanford University

    Medical School





    Stanford University


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Matthew Gubens has contributed to 3 publications.

    Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

    Sanlorenzo, M.,Vujic, I.,Daud, A.,Algazi, A.,Gubens, M.,Luna, S. A.,Lin, K.,Quaglino, P.,Rappersberger, K.,Ortiz-Urda, S.; JAMA Dermatol. 2015 Jul 30.

    See more >>

    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors.

    Smith, D. C.,Eisenberg, P. D.,Manikhas, G.,Chugh, R.,Gubens, M. A.,Stagg, R. J.,Kapoun, A. M.,Xu, L.,Dupont, J.,Sikic, B.; Clin. Cancer Res.. 2014 Oct 18.

    See more >>

    Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.

    Woodard, G. A.,Gubens, M. A.,Jahan, T. M.,Jones, K. D.,Kukreja, J.,Theodore, P. R.,Cardozo, S.,Jew, G.,Clary-Macy, C.,Jablons, D. M.,Mann, M. J.; Clin Lung Cancer. 2014 Sep 27.

    See more >>